A history of moderate to severe traumatic brain injury is associated with an increased risk of malignant brain tumors, data suggest.

The FDA is moving to abandon a decades-old policy of asking advisory committees to review drug applications, and critics say the move could shield the agency's decisions from public scrutiny.

Our findings continue to highlight the complex landscape of cancer care costs and call for further research and policy changes,” the researchers wrote.

It was difficult to determine the effect of bevacizumab on survival in this analysis because details on adjuvant therapy, maintenance therapy, and BRCA or HRD status were not available, the ...

Cancer Therapy Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve ...

These results support the view that a considerable proportion of cancers arise from stochastic processes, rather than being solely driven by hereditary factors or environmental exposures,” the ...

Adding osimertinib to platinum-based chemotherapy may improve outcomes in patients with EGFR-mutant, advanced NSCLC who had disease progression on first-line osimertinib.

As many as 1 in 5 medical students in the United States may be food-insecure, according to a study published in JAMA Network Open. Researchers surveyed 1834 medical students attending 8 schools ...

Cancer survivors' care can be improved with better coordination between oncologists and primary care providers, experts say.

Peer review and the editorial process yield frequent improvements in research abstracts of randomized clinical trial reports, data suggest.

Data from the HARMONi trial suggest that outcomes may differ between patients in China and those in North America or Europe.